Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection

2019 ◽  
Vol 25 (3) ◽  
pp. 425-435 ◽  
Author(s):  
Caroline C. Jadlowiec ◽  
Paige E. Morgan ◽  
Avinash K. Nehra ◽  
Matthew A. Hathcock ◽  
Walter K. Kremers ◽  
...  
1987 ◽  
Vol 43 (2) ◽  
pp. 169-172 ◽  
Author(s):  
JOHN A. WOLFE ◽  
JAMES BURCHETTE ◽  
FRED SANFILIPPO ◽  
R. RANDAL BOLLINGER ◽  
STUART J. KNECHTLE

Hepatology ◽  
1999 ◽  
Vol 29 (3) ◽  
pp. 777-784 ◽  
Author(s):  
Yasuo Yamaguchi ◽  
Kazutoshi Okabe ◽  
Fujio Matsumura ◽  
Eiji Akizuki ◽  
Teishi Matsuda ◽  
...  

Hepatology ◽  
1991 ◽  
Vol 13 (6) ◽  
pp. 1117-1125 ◽  
Author(s):  
Preston F. Foster ◽  
Achyut Bhattacharyya ◽  
Howard N. Sankary ◽  
James Coleman ◽  
Marilyn Ashmann ◽  
...  

1989 ◽  
Vol 47 (1) ◽  
pp. 74-76 ◽  
Author(s):  
Howard Sankary ◽  
Preston Foster ◽  
Marquis Hart ◽  
Marilyn Ashmann ◽  
Daniel Schwartz ◽  
...  

1989 ◽  
Vol 64 (5) ◽  
pp. 565-569 ◽  
Author(s):  
JAMES D. PERKINS ◽  
JORGE RAKELA ◽  
SYLVESTER STERIOFF ◽  
PETER M. BANKS ◽  
RUSSELL H. WIESNER ◽  
...  

2002 ◽  
Vol 283 (1) ◽  
pp. G196-G203 ◽  
Author(s):  
John Wong ◽  
Paul Kubes ◽  
Yikun Zhang ◽  
Yang Li ◽  
Stefan J. Urbanski ◽  
...  

The pathogenesis of hepatic allograft rejection remains unclear. We aimed to clarify the early role of intercellular adhesion molecule-1 (ICAM-1)-mediated cell recruitment in chronic hepatic rejection. Liver transplantation was performed from Lewis to Lewis rats (isograft controls) and from Lewis to Brown Norway rats (allograft rejection group). The allografted rats were treated with either ICAM-1 antisense oligonucleotides (10 mg · kg−1· day−1× 6 days ip) or a control preparation (either ICAM-1 missense oligonucleotide or normal saline). Hepatic leukocyte recruitment in vivo was studied on day 6 by using intravital microscopy. Liver histology, biochemistry, and survival rates were also examined. Leukocyte adhesion in terminal hepatic venules was significantly increased in the rejection group compared with isograft controls. Antisense ICAM-1 in the allografted group effectively reduced leukocyte adhesion. Histology and liver chemistry were less deranged in the antisense-treated groups compared with control-treated allografted rats. In the allograft groups, survival was significantly prolonged in the antisense-treated rats (42.3 ± 1.2 days) compared with the controls (25.2 ± 2.7 days). These results showed that early leukocyte recruitment in the hepatic microvasculature of rejecting allografts is ICAM-1 dependent and suggest that impacting on early cell recruitment can significantly ameliorate chronic rejection.


1992 ◽  
Vol 53 (6) ◽  
pp. 1195-1201 ◽  
Author(s):  
TAKESHI TONO ◽  
MORITO MONDEN ◽  
KAZUYUKI YOSHIZAKI ◽  
LUIS A. VALDIVIA ◽  
YOSHIAKI NAKANO ◽  
...  

1996 ◽  
Vol 61 (9) ◽  
pp. 1365-1369 ◽  
Author(s):  
J. Michael Millis ◽  
E. Steve Woodle ◽  
James B. Piper ◽  
David S. Bruce ◽  
Kenneth A. Newell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document